Connect your AI

Arrowhead Research ARWR Free cash flow

Free cash flow at other companies

AbbVieABBV

$3.56B+155%

Ionis PharmaceuticalsIONS

——

ALN

Alnylam PharmaceuticalsALNY

——

BridgeBio PharmaBBIO

——

Madrigal Pharmaceuticals, Inc.MDGL

——

RevvityRVTY

——

Other financials

Income statement

Revenue$73.7M-86.4%

Operating income-$141.3M-137%

Net income-$132.7M-136%

EPS (diluted)-$0.93-134%

Balance sheet

Cash & equivalents$188.5M+1.5%

Total debt$107.9M-5.6%

Total equity$614.0M-10.1%

Total assets$2.3B+44.2%

Cash flow

Operating cash flow$84.4M-81.6%

CapEx$2.6M-51.6%

Valuation

Market cap$11.52B+402%

Enterprise value$11.44B+418%

P/S18.5×+14.3×

Profitability

Operating margin-35.7%+63.6pp

Net margin-48.4%+240pp

FCF margin1.8%+0.9pp

Returns & leverage

Return on equity-46.4%+341pp

Debt / equity0.2×0.0×

Current ratio6.2×+1.1×

Where this comes from

Calculated from Arrowhead Research’s reported figures.

$84.4Mnet cash from operating−$2.6Mcapital expenditures=$81.88M

The official record: Arrowhead Research’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Arrowhead Research's free cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Arrowhead Research's free cash flow?: Arrowhead Research (ARWR) reported free cash flow of $81.88M in Q1 2026.
How has Arrowhead Research's free cash flow changed year-over-year?: Arrowhead Research's free cash flow decreased by 82.0% year-over-year, from $454.76M to $81.88M.